This federal contract award to Visiopharm Corporation, a foreign-owned, for-profit organization, is for DIGITAL PATHOLOGY ANALYSIS SOFTWARE. The $98,346.00 firm-fixed-price purchase order was awarded by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs. The contract has an ultimate completion date of October 16, 2017 and does not utilize a set-aside designation. Visiopharm Corporation is a subsidiary of Visiopharm A/S, headquartered in...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Visiopharm Corporation, a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions. The contract is for VISIOPHARM SOFTWARE MAINTENANCE, with a ceiling value of $31,600.00 and a period of performance ending on April 30, 2024. The contract was not set aside for any specific business category. Visiopharm Corporation is a wholly-owned...
Visiopharm Corporation, a foreign-owned for-profit organization, was awarded a $24,775.60 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software with a completion date of February 14, 2025. The award was made on February 15, 2024 without a set-aside designation. Visiopharm will provide its precision pathology software for research and diagnostics, leveraging over 20 years of experience...
This $79,800.00 firm-fixed-price purchase order from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) awarded to Visiopharm Corporation, a foreign-owned for-profit organization, provides 12-month licenses for Visiopharm's AI-powered image analysis software, Octotopix, and Translational Research Software. The software will support digital pathology and assist pathologists at the NCI's Laboratory of Pathology in analyzing patient tissue samples and providing more...
The U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 20, awarded a $12,600.00 firm-fixed-price purchase order contract to Visiopharm Corporation, a Denmark-based, for-profit company specializing in digital pathology software and solutions. The contract, awarded on July 25, 2023, has a performance period through July 24, 2026. Visiopharm Corporation, a wholly owned subsidiary of Visiopharm A/S, is providing its VISIOPHARM precision pathology software,...
This firm-fixed-price purchase order was awarded by the U.S. Department of Defense's Medical Command (MEDCOM) to Molecular Devices LLC, a subsidiary of Danaher Corporation, for an ImageXpress Pico EC System with Cell Reporter Xpress automated image acquisition and analysis software. The $78,440 contract provides a perpetual software license allowing five concurrent users and analysis on up to ten computer cores. The system delivers standard image analysis algorithms for cell counting, scoring,...
This is a firm-fixed-price purchase order awarded by the National Institute of Dental and Craniofacial Research, part of the U.S. Department of Health and Human Services, to Visiopharm Corporation, a foreign-owned, for-profit software company specializing in digital pathology solutions. The $97,210.00 contract is for HISTOPATHOLOGICAL AI ANALYSIS SOFTWARE, which will support research and diagnostic efforts across the federal government. The award is designated as a Total Small Business...
This federal contract award was made by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Visiopharm Corporation, a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions. The $63,750.00 firm-fixed-price purchase order is for VISIOPHARM DIGITAL PATHOLOGY SUBSCRIPTIONS and PHENOPLEX SOFTWARE UPGRADES. The contract did not utilize a set-aside designation. Visiopharm Corporation is a wholly-owned...
The U.S. Defense Health Agency (DHA) awarded a $82,190.00 firm-fixed-price purchase order contract to Visiopharm Corporation for the procurement of OCUS40 digital microscopes. The contract has a completion date of October 29, 2023 and was set aside for total small business participation. Visiopharm Corporation is a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions, and is a wholly-owned subsidiary of the manufacturer Visiopharm...
Open Eye Scientific Software, Inc. was awarded a firm fixed-price purchase order for $47,250 by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to provide an annual unlimited software license for the Open Eye Modeling and Virtual Screening Software package. The license will enable the National Center for Advancing Translational Sciences to utilize proprietary molecular modeling and cheminformatics software tools from...